In our previous gene expression profile analysis (GSE54936 and GSE53464) [25, 26], FoxM1 was downregulated in human glioma and ovarian cancer cells after treatment with the Hh-Gli signaling pathway inhibitor GANT61 [27, 28]. This evidence concerns the gene FOXM1 and glioma.